The normal duct-lobular system of the breast is lined by two epithelial cell types, inner luminal secretory cells and outer contractile myoepithelial cells. We have generated comprehensive expression profiles of the two normal cell types, using immunomagnetic cell separation and gene expression microarray analysis. The cell-type specificity was confirmed at the protein level by immunohistochemistry in normal breast tissue. New prognostic markers for survival were identified when the luminal- and myoepithelial-specific molecules were evaluated on breast tumor tissue microarrays. Nuclear expression of luminal epithelial marker galectin 3 correlated with a shorter overall survival in these patients, and the expression of SPARC (osteonectin), a myoepithelial marker, was an independent marker of poor prognosis in breast cancers as a whole. These data provide a framework for the interpretation of breast cancer molecular profiling experiments, the identification of potential new diagnostic markers, and development of novel indicators of prognosis.

Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells: Identification of Novel Prognostic Markers for Breast Cancer / Jones, C.; Mackay, A.; Grigoriadis, A.; Cossu, A.; Reis-Filho, J. S.; Fulford, L.; Dexter, T.; Davies, S.; Bulmer, K.; Ford, E.; Parry, S.; Budroni, M.; Palmieri, G.; Neville, A. M.; O'Hare, M. J.; Lakhani, S. R.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 64:9(2004), pp. 3037-3045. [10.1158/0008-5472.CAN-03-2028]

Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells: Identification of Novel Prognostic Markers for Breast Cancer

Cossu A.;Palmieri G.;
2004-01-01

Abstract

The normal duct-lobular system of the breast is lined by two epithelial cell types, inner luminal secretory cells and outer contractile myoepithelial cells. We have generated comprehensive expression profiles of the two normal cell types, using immunomagnetic cell separation and gene expression microarray analysis. The cell-type specificity was confirmed at the protein level by immunohistochemistry in normal breast tissue. New prognostic markers for survival were identified when the luminal- and myoepithelial-specific molecules were evaluated on breast tumor tissue microarrays. Nuclear expression of luminal epithelial marker galectin 3 correlated with a shorter overall survival in these patients, and the expression of SPARC (osteonectin), a myoepithelial marker, was an independent marker of poor prognosis in breast cancers as a whole. These data provide a framework for the interpretation of breast cancer molecular profiling experiments, the identification of potential new diagnostic markers, and development of novel indicators of prognosis.
2004
Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells: Identification of Novel Prognostic Markers for Breast Cancer / Jones, C.; Mackay, A.; Grigoriadis, A.; Cossu, A.; Reis-Filho, J. S.; Fulford, L.; Dexter, T.; Davies, S.; Bulmer, K.; Ford, E.; Parry, S.; Budroni, M.; Palmieri, G.; Neville, A. M.; O'Hare, M. J.; Lakhani, S. R.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 64:9(2004), pp. 3037-3045. [10.1158/0008-5472.CAN-03-2028]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/241305
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 223
  • ???jsp.display-item.citation.isi??? 221
social impact